Amedeo Smart

Free Medical Literature Service

 

Amedeo

Leukemia
  Free Subscription

Articles published in
Br J Cancer
    March 2024
  1. LITTLE MP, Eidemuller M, Kaiser JC, Apostoaei AI, et al
    Minimum latency effects for cancer associated with exposures to radiation or other carcinogens.
    Br J Cancer. 2024;130:819-829.
    >> Share

    February 2024
  2. ZAKKAK N, Barclay ME, Swann R, McPhail S, et al
    The presenting symptom signatures of incident cancer: evidence from the English 2018 National Cancer Diagnosis Audit.
    Br J Cancer. 2024;130:297-307.
    >> Share

  3. GUTIERREZ-CAMINO A, Richer C, Ouimet M, Fuchs C, et al
    Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia.
    Br J Cancer. 2024;130:317-326.
    >> Share

    January 2024
  4. HEYMER EJ, Hawkins MM, Winter DL, Teepen JC, et al
    Risk of subsequent gliomas and meningiomas among 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study.
    Br J Cancer. 2024 Jan 19. doi: 10.1038/s41416-024-02577.
    >> Share

    October 2023
  5. LITTLE MP, Wakeford R, Zablotska LB, Borrego D, et al
    Radiation exposure and leukaemia risk among cohorts of persons exposed to low and moderate doses of external ionising radiation in childhood.
    Br J Cancer. 2023;129:1152-1165.
    >> Share

    September 2023
  6. LORENZINI T, Cadilha BL, Obeck H, Benmebarek MR, et al
    Rational design of PD-1-CD28 immunostimulatory fusion proteins for CAR T cell therapy.
    Br J Cancer. 2023;129:696-705.
    >> Share

    July 2023
  7. GUPTA DG, Varma N, Sreedharanunni S, Abdulkadir SA, et al
    'Evaluation of adverse prognostic gene alterations & MRD positivity in BCR::ABL1-like B-lineage acute lymphoblastic leukaemia patients, in a resource-constrained setting.
    Br J Cancer. 2023;129:143-152.
    >> Share

    June 2023
  8. BEDICS G, Egyed B, Kotmayer L, Benard-Slagter A, et al
    PersonALL: a genetic scoring guide for personalized risk assessment in pediatric B-cell precursor acute lymphoblastic leukemia.
    Br J Cancer. 2023 Jun 21. doi: 10.1038/s41416-023-02309.
    >> Share

    May 2023
  9. CROMIE KJ, Hughes NF, Milner S, Crump P, et al
    Socio-economic and ethnic disparities in childhood cancer survival, Yorkshire, UK.
    Br J Cancer. 2023;128:1710-1722.
    >> Share

    March 2023
  10. LIU HC, Kuo MC, Wu KH, Chen TY, et al
    Children with chronic myeloid leukaemia treated with front-line imatinib have a slower molecular response and comparable survival compared with adults: a multicenter experience in Taiwan.
    Br J Cancer. 2023;128:1294-1300.
    >> Share

    February 2023
  11. WANG L, Zhang Q, Ye L, Ye X, et al
    All-trans retinoic acid enhances the cytotoxic effect of decitabine on myelodysplastic syndromes and acute myeloid leukaemia by activating the RARalpha-Nrf2 complex.
    Br J Cancer. 2023;128:691-701.
    >> Share

    November 2022
  12. SUNGUC C, Hawkins MM, Winter DL, Dudley IM, et al
    Risk of subsequent primary oral cancer in a cohort of 69,460 5-year survivors of childhood and adolescent cancer in Europe: the PanCareSurFup study.
    Br J Cancer. 2022 Nov 1. pii: 10.1038/s41416-022-02016.
    >> Share

    September 2022
  13. VENN NC, Huang L, Hovorkova L, Muskovic W, et al
    Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions.
    Br J Cancer. 2022;127:908-915.
    >> Share

    July 2022
  14. SELLIN M, Mack R, Rhodes MC, Zhang L, et al
    Molecular mechanisms by which splice modulator GEX1A inhibits leukaemia development and progression.
    Br J Cancer. 2022;127:223-236.
    >> Share

    February 2022
  15. JIANG Y, Southam AD, Trova S, Beke F, et al
    Valproic acid disables the Nrf2 anti-oxidant response in acute myeloid leukaemia cells enhancing reactive oxygen species-mediated killing.
    Br J Cancer. 2022;126:275-286.
    >> Share

  16. SUBHASH VV, Huang L, Kamili A, Wong M, et al
    Whole-genome sequencing facilitates patient-specific quantitative PCR-based minimal residual disease monitoring in acute lymphoblastic leukaemia, neuroblastoma and Ewing sarcoma.
    Br J Cancer. 2022;126:482-491.
    >> Share

    September 2021
  17. TARIQ MU, Furqan M, Parveen H, Ullah R, et al
    CCT245718, a dual FLT3/Aurora A inhibitor overcomes D835Y-mediated resistance to FLT3 inhibitors in acute myeloid leukaemia cells.
    Br J Cancer. 2021;125:966-974.
    >> Share

    July 2021
  18. MOGENSEN H, Modig K, Talback M, Erdmann F, et al
    Number of siblings and survival from childhood leukaemia: a national register-based cohort study from Sweden.
    Br J Cancer. 2021;125:112-118.
    >> Share

  19. KARSA M, Kosciolek A, Bongers A, Mariana A, et al
    Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin.
    Br J Cancer. 2021;125:55-64.
    >> Share

    May 2021
  20. SONG S, Zhang J, Su Q, Zhang W, et al
    Downregulation of ITGA6 confers to the invasion of multiple myeloma and promotes progression to plasma cell leukaemia.
    Br J Cancer. 2021;124:1843-1853.
    >> Share

    February 2021
  21. PINTO-FERNANDEZ A, Salio M, Partridge T, Chen J, et al
    Deletion of the deISGylating enzyme USP18 enhances tumour cell antigenicity and radiosensitivity.
    Br J Cancer. 2021;124:817-830.
    >> Share

    January 2021
  22. BARROW TM, Nakjang S, Lafta F, Bilotkach K, et al
    Epigenome-wide analysis reveals functional modulators of drug sensitivity and post-treatment survival in chronic lymphocytic leukaemia.
    Br J Cancer. 2021;124:474-483.
    >> Share

    December 2020
  23. PUETT RC, Poulsen AH, Taj T, Ketzel M, et al
    Relationship of leukaemias with long-term ambient air pollution exposures in the adult Danish population.
    Br J Cancer. 2020;123:1818-1824.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016